Obsidian Therapeutics
PrivateLast Round
Private Placement
Apr 14, 2026
Total Funding Raised
$325M
Momentum Score
50 /100
Company Overview
Obsidian Therapeutics is a biotechnology company that develops next-generation controllable cell and gene therapies designed to enhance adoptive immunotherapy for all cancer patients through innovative pharmacologic operating systems that allow physicians to precisely manage protein activity in cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Obsidian Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Obsidian Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Apr 14, 2026 | ||||
| Series C | Apr 3, 2024 | ||||
| Series B | Sep 9, 2021 | ||||
| Series A | Dec 6, 2017 |
Obsidian Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Private Placement |
| Soleus Capital | Series B |
| Janus Henderson Group | Series C, Private Placement |
| Balyasny Asset Management L.P. | Private Placement |
| RA Capital Management | Series C, Series B, Private Placement |
| TCG Crossover | Series C, Series B |
| Vertex Ventures HC | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
All-stock merger agreement with Galera Therapeutics announced.
- Apr 14, 2026
$350M raised in a Private Placement round.
Obsidian Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Obsidian Therapeutics's valuation, stock price, and market status.
